Name | Number of supported studies | Average coverage | |
---|---|---|---|
erythrocyte | 9 studies | 46% ± 17% | |
natural killer cell | 7 studies | 18% ± 4% | |
mature NK T cell | 3 studies | 18% ± 1% | |
epithelial cell | 3 studies | 22% ± 5% | |
ciliated cell | 3 studies | 23% ± 4% |
Insufficient scRNA-seq data for expression of BPGM at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1031.26 | 1445 / 1445 | 100% | 35.61 | 183 / 183 |
kidney | 100% | 1706.98 | 89 / 89 | 100% | 47.94 | 900 / 901 |
brain | 100% | 1236.39 | 2640 / 2642 | 100% | 51.01 | 704 / 705 |
ovary | 100% | 548.76 | 180 / 180 | 100% | 25.78 | 429 / 430 |
breast | 100% | 864.42 | 459 / 459 | 100% | 36.97 | 1115 / 1118 |
prostate | 100% | 921.04 | 245 / 245 | 100% | 27.51 | 500 / 502 |
thymus | 100% | 770.48 | 652 / 653 | 100% | 30.64 | 603 / 605 |
lung | 99% | 955.97 | 575 / 578 | 100% | 39.47 | 1153 / 1155 |
skin | 100% | 746.81 | 1804 / 1809 | 99% | 32.08 | 468 / 472 |
bladder | 100% | 973.76 | 21 / 21 | 99% | 63.37 | 497 / 504 |
uterus | 99% | 706.66 | 168 / 170 | 100% | 45.74 | 458 / 459 |
adrenal gland | 100% | 903.07 | 258 / 258 | 98% | 26.64 | 226 / 230 |
stomach | 100% | 748.93 | 359 / 359 | 94% | 18.11 | 270 / 286 |
pancreas | 95% | 371.62 | 310 / 328 | 99% | 31.63 | 176 / 178 |
intestine | 100% | 850.86 | 966 / 966 | 93% | 16.20 | 489 / 527 |
liver | 97% | 394.30 | 219 / 226 | 94% | 17.20 | 380 / 406 |
adipose | 100% | 818.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 3139.96 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 978.36 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 43.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.94 | 1 / 1 |
blood vessel | 100% | 1006.90 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 915.35 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 665.30 | 809 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 19.50 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 85% | 13.74 | 68 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015671 | Biological process | oxygen transport |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0060856 | Biological process | establishment of blood-brain barrier |
GO_0048821 | Biological process | erythrocyte development |
GO_0042832 | Biological process | defense response to protozoan |
GO_0150076 | Biological process | neuroinflammatory response |
GO_0006096 | Biological process | glycolytic process |
GO_1901136 | Biological process | carbohydrate derivative catabolic process |
GO_0007585 | Biological process | respiratory gaseous exchange by respiratory system |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0046538 | Molecular function | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO_0016787 | Molecular function | hydrolase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004082 | Molecular function | bisphosphoglycerate mutase activity |
Gene name | BPGM |
Protein name | Bisphosphoglycerate mutase (BPGM) (EC 5.4.2.4) (2,3-bisphosphoglycerate mutase, erythrocyte) (2,3-bisphosphoglycerate synthase) (EC 5.4.2.11) (2,3-diphosphoglycerate mutase) (DPGM) (BPG-dependent PGAM) Phosphoglycerate mutase (EC 5.4.2.11) (EC 5.4.2.4) |
Synonyms | |
Description | FUNCTION: Plays a major role in regulating hemoglobin oxygen affinity by controlling the levels of its allosteric effector 2,3-bisphosphoglycerate (2,3-BPG). Also exhibits mutase (EC 5.4.2.11) activity. . FUNCTION: Plays a major role in regulating hemoglobin oxygen affinity by controlling the levels of its allosteric effector 2,3-bisphosphoglycerate (2,3-BPG). Also exhibits mutase (EC 5.4.2.11) activity. . |
Accessions | ENST00000393132.2 ENST00000418040.5 ENST00000344924.8 ENST00000443095.1 C9JH23 P07738 |